Dralserp
Dralserp Brand names, Dralserp Analogs
- Cam-Ap-Es
- Demi-Regroton
- Diupres-250
- Diupres-500
- Diutensen-R
- Dralserp
- Hiserpia
- Hydrap-ES
- Hydromox R
- Hydroserpine Plus (R-H-H)
- Metatensin #2
- Metatensin #4
- Naquival
- Novoreserpine
- Rau-Sed
- Regroton
- Renese-R
- Reserfia
- Salutensin
- Salutensin-Demi
- Sandril
- Ser-A-Gen
- Serpalan
- Serpalan (TN)
- Serpanray
- Serpasil
- Serpasil-Apresoline
- Serpasil-Esidrix #1
- Serpasil-Esidrix #2
- Serpate
- Serpivite
- Unipres
Dralserp Brand Names Mixture
- Hydropres 25 Tab (Hydrochlorothiazide + Reserpine)
- Hydropres 50 Tab (Hydrochlorothiazide + Reserpine)
- SER-AP-ES Tab (Hydralazine Hydrochloride + Hydrochlorothiazide + Reserpine)
Dralserp Chemical_Formula
C33H40N2O9
Dralserp RX_link
No information avaliable
Dralserp fda sheet
Dralserp msds (material safety sheet)
Dralserp Synthesis Reference
No information avaliable
Dralserp Molecular Weight
608.679 g/mol
Dralserp Melting Point
264.5 oC
Dralserp H2O Solubility
73 mg/L
Dralserp State
Solid
Dralserp LogP
3.32
Dralserp Dosage Forms
Tablets
Dralserp Indication
Foe the treatment of hypertension
Dralserp Pharmacology
Reserpine is an adrenergic blocking agent used to treat mild to moderate hypertension via the disruption of norepinephrine vesicular storage. The antihypertensive actions of Reserpine are a result of its ability to deplete catecholamines from peripheral sympathetic nerve endings. These substances are normally involved in controlling heart rate, force of cardiac contraction and peripheral resistance.
Dralserp Absorption
No information avaliable
Dralserp side effects and Toxicity
Possible human carcinogen. May cause reproductive harm. ORL-RAT LD50 420 mg/kg; IPR-RAT LD50 44 mg/kg; IVN-RAT LD50 15 mg/kg; ORL-MUS LD50 200 mg/kg; SCU-MUS LD50 52 mg/kg; IPR-RBT LD50 7 mg/kg
Dralserp Patient Information
No information avaliable
Dralserp Organisms Affected
Humans and other mammals
